Will Teva Pharmaceutical (TEVA) Stock Rise Following BMO Capital Upgrade? – TheStreet.com


International Business Times
Will Teva Pharmaceutical (TEVA) Stock Rise Following BMO Capital Upgrade?
TheStreet.com
NEW YORK (TheStreet) — Shares of Teva Pharmaceutical Industries Ltd. (TEVA – Get Report) were down 1.36% to $71.09 in mid-morning trading Tuesday, after analysts at BMO Capital Markets upgraded shares of the pharmaceutical company this morning.
Teva Pharmaceuticals Stands To Lose Around $300 Million On Mylan TradeForbes
Teva And Allergan Acquisition: Why Are Pharmaceutical Companies Making So Many International Business Times
Israeli pharmaceutical giant Teva buys Allergan’s generic drug business for $40.5B680 News
CNA Finance (press release) -Motley Fool
all 881 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd